Rutgeerts Rutgeerts P P D’Haens D’Haens G G Targan Targan S S Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease Gastroenterology Gastroenterology 1999 1999 117 117 761 761 769 769 10.1016/S0016-5085(99)70332-X 10.1016/S0016-5085(99)70332-X supplied-pmid 10500056? This evidence concerns the gene TNF and Crohn disease.